Nathaniel Wang
CEO Replicate Bioscience
Seminars
Tuesday 21st July 2026
CEO & mRNA Leaders Think Tank: From CAR-T Platforms, Gene Editing Triumphs & Cancer Immunotherapy Clinical Advances; Navigating mRNA’s Potential into New Therapies & Tools Towards Better Drugs for Patients Faster
9:00 am
- What are the future opportunities, promising targets and applications on the horizon for mRNA to achieve commercial success?
- How are recent mRNA and LNP platform acquisitions fueling next generation innovations from science to strategy?
- Linear, circular, self-amplifying, trans-amplifying RNA – Which modality offers the most efficiency?
- With clinical trials moving towards the far East and Australia, what opportunities does this open for the mRNA industry to progress faster to clinical validation?
Tuesday 21st July 2026
Optimized Self-Replicating RNA Enable Clinical Applications for Multiplexed Vaccines & Vectorized Biotherapeutics
4:15 pm
- Clean-PIE circRNA platform of CureMed
- cmRNA1210: CircRNA based IL-12 for solid tumor
- CircRNA based in vivo TCE/CAR-T
